6-Bromoquinazoline(CAS: 89892-21-7)

6-Bromoquinazoline (CAS: 89892-21-7) is subject to regulatory guidelines including GHS classification, REACH regulations, and FDA/EPA requirements for handling and disposal. It is recommended to consult the latest regulatory documents for specific guidelines and compliance requirements.

Yes, there are alternatives to 6-Bromoquinazoline (CAS: 89892-21-7) in synthesis, such as bromination of quinazoline derivatives using other reagents like N-bromosuccinimide (NBS) or N-iodosuccinimide (NIS). These alternatives offer similar functionalization but with potentially different reactivity and selectivity.

The market for 6-Bromoquinazoline (CAS: 89892-21-7) is growing due to increasing interest in its use as a key intermediate in the synthesis of bioactive compounds and pharmaceuticals. Research trends include the development of more efficient synthesis methods and the exploration of its applications in drug discovery.

Waste containing 6-Bromoquinazoline (CAS: 89892-21-7) should be collected in appropriate containers and disposed of according to local regulations. Incineration is a common method for disposal, but professional waste disposal services are recommended to ensure environmental safety and compliance with regulations.